Position in HIMS
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$450,575
-$506,640 QoQ
Shares Held
21,704
-26.4% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Kestra Advisory Services, LLC holds $8,161,285 across 14 Drug Manufacturers - Specialty & Generic names. HIMS ranks #5 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
23,140 | $2,735,379 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
47,388 | $1,427,326 | |
| 3 | VTRS |
Viatris Inc
|
90,526 | $1,223,006 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
1,288 | $763,758 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
This page
|
21,704 | $450,575 | |
| 6 | HLN |
Haleon plc
|
42,584 | $426,265 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
12,022 | $287,686 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
3,329 | $252,504 |
All Filings in HIMS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $450,575 | 21,704 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $957,215 | 29,480 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,809,171 | 49,527 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,678,549 | 33,672 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $404,155 | 13,677 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $354,164 | 14,647 | Shares | Sole | 2025-02-10 | |
| No filing history on record for this holder in this stock. | ||||||